AZD-6422, a novel dnTGFββRII-armored, CLDN18.2-targeted CAR T therapeutic
Nov. 16, 2023
CLDN18 is a cell surface membrane protein involved in the formation of tight junctions, and the expression of its CLDN18.2 isoform has been observed in pancreatic, gastric and esophageal tumors.